Month: April 2024

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call. The Company will release its first quarter 2024 results on Tuesday, May 7th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, May 7th, 2024. The call can be accessed at (800) 717-1738, conference ID 1112534. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available...

IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it has secured $200 million in committed capital from funds associated with Pharmakon Advisors, LP. Tarsus has elected to draw $75 million on the closing date, April 19, 2024, with the remaining $125 million of committed capital available at the company’s option in three tranches through specified time windows, the last ending in December 2025. Net proceeds to the Company at closing will be approximately $40 million following the repayment of the existing credit facility, as well as fees and expenses associated with the transaction. The new five-year interest-only credit...

WOBURN, Mass., April 23, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), A global leader in AI-powered marketing technology, announces its partnership with Springthrough Agency to leverage Bridgeline’s HawkSearch AI technology to grow revenue for eCommerce websites on the Sitefinity platform. Springthrough will partner with HawkSearch to increase revenue growth for their customer base through eCommerce search, product discovery, and recommendations.The partnership allows thousands of Progress Sitefinity customers easy access to HawkSearch AI-powered search. Springthrough brings knowledge and expertise as a Premier Sitefinity Partner and a recipient of the Sitefinity Champion Award. HawkSearch is a leading site search technology for Sitefinity users, currently powering search for brands such as RDO Equipment,...

CHICAGO, April 23, 2024 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the first quarter 2024 on Tuesday, May 7, 2024. Management will host a webcast and conference call on Tuesday, May 7, 2024 at 10:00 a.m. ET to discuss the results and provide a business update. The conference call will be available via public webcast through the Public Shareholders section of GCM Grosvenor’s website at www.gcmgrosvenor.com/public-shareholders and a replay will be available on the website soon after the call’s completion for at least seven (7) days. To register for the call, visit www.gcmgrosvenor.com/public-shareholders. About GCM Grosvenor GCM Grosvenor (Nasdaq: GCMG) is a global alternative asset management solutions provider with...

HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas.Presentation Date: May 1, 2024Time: 2:30pm Pacific TimeWebcast Link: https://www.webcaster4.com/Webcast/Page/3026/50402   Dr. Rafaeli will be available for one-on-one meetings throughout the conference. Investors can attend the conference and request a meeting with Dr. Rafaeli by registering at the link...

Provides Further Evidence of Multiple Opportunities for Development of the FABP Inhibitor Platform in Cancer & Other Serious Conditions SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, and neurological conditions, today announced the publication of an article, “The emerging role of fatty acid binding protein 7 (FABP7) in cancers,” in Drug Discovery Today, a peer-reviewed journal. The article analyzes the results of various studies and presents a comprehensive analysis of FABP7’s role in a variety of cancers and its correlation with patient prognosis, as well as its potential utility as a validated target in cancer treatment. The...

CHICAGO, April 23, 2024 (GLOBE NEWSWIRE) — SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announces its strategic partnership with the City of Jackson, Mississippi, to modernize and enhance the efficiency of on-street parking with a completely new and innovative system. Available this spring, on-street parking customers will be able to pay for parking using new kiosks located throughout the city, in addition to other payment methods, including text-to-pay with their phone, or via the parking.com app. SP+ Corporation will also assist the city with parking enforcement activities. These efforts will be streamlined by providing vehicles equipped with License...

The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, a premier healthcare technology company for the pharmaceutical industry. The new partnership will increase access to GeneDx’s extensive de-identified rare disease data set, now available through Komodo Health’s MapEnhance offering, including data from more than 500,000 exomes, enabling biopharma companies to access genetic insights that can help inform drug pipelines and accelerate clinical trial enrollment. “The partnership between GeneDx and Komodo Health represents...

SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA), a company known for its groundbreaking innovations in entertainment experiences, has announced today that Altimedia, a provider of solutions for managing advanced media services, has signed a multi-year license renewal for access to Adeia’s media intellectual property (IP) portfolio. Altimedia offers a user experience (UX) platform to pay-TV and digital media service providers in the Korean market. Their platform empowers these providers with cutting-edge technology that enables consumers to navigate various services or applications and access the content they seek. Altimedia is recognized as a leading IPTV-based platform and UX service management provider that delivers the latest advancements in content search and recommendation. “The user interface...